DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,977,000 | +5.0% | 49,412 | +1.8% | 1.26% | -5.3% |
| Q3 2020 | $10,453,000 | +25.3% | 48,543 | +2.9% | 1.33% | +12.4% |
| Q2 2020 | $8,344,000 | +29.9% | 47,188 | +1.7% | 1.18% | +5.0% |
| Q1 2020 | $6,425,000 | -8.5% | 46,418 | +1.4% | 1.13% | +12.5% |
| Q4 2019 | $7,024,000 | +6.3% | 45,763 | -0.0% | 1.00% | -2.1% |
| Q3 2019 | $6,610,000 | -0.9% | 45,768 | -1.9% | 1.02% | -2.9% |
| Q2 2019 | $6,669,000 | -21.5% | 46,663 | -27.5% | 1.05% | -23.9% |
| Q1 2019 | $8,498,000 | +27.9% | 64,366 | -0.1% | 1.38% | +20.3% |
| Q4 2018 | $6,646,000 | -8.5% | 64,451 | -3.6% | 1.15% | +15.5% |
| Q3 2018 | $7,267,000 | +13.0% | 66,878 | +2.6% | 1.00% | +6.9% |
| Q2 2018 | $6,429,000 | +0.8% | 65,153 | +0.0% | 0.93% | -1.9% |
| Q1 2018 | $6,378,000 | +2.9% | 65,143 | -0.1% | 0.95% | +4.9% |
| Q4 2017 | $6,196,000 | +16.6% | 65,233 | +5.3% | 0.90% | +42.3% |
| Q3 2017 | $5,316,000 | +11.3% | 61,977 | +9.5% | 0.64% | -11.4% |
| Q2 2017 | $4,776,000 | +0.5% | 56,590 | +1.8% | 0.72% | +6.8% |
| Q1 2017 | $4,752,000 | +4.7% | 55,565 | -4.7% | 0.67% | -12.7% |
| Q4 2016 | $4,537,000 | +4.1% | 58,290 | +4.8% | 0.77% | -3.3% |
| Q3 2016 | $4,359,000 | -22.3% | 55,605 | +0.1% | 0.80% | -34.1% |
| Q2 2016 | $5,608,000 | +11.3% | 55,524 | +4.6% | 1.21% | -0.8% |
| Q1 2016 | $5,037,000 | +9.1% | 53,099 | +6.8% | 1.22% | +17.0% |
| Q4 2015 | $4,616,000 | +10.2% | 49,699 | +1.1% | 1.04% | +1.7% |
| Q3 2015 | $4,190,000 | -1.0% | 49,174 | -0.5% | 1.02% | +8.1% |
| Q2 2015 | $4,231,000 | +1.5% | 49,435 | +0.7% | 0.95% | +0.7% |
| Q1 2015 | $4,167,000 | +3.7% | 49,085 | +4.7% | 0.94% | -1.4% |
| Q4 2014 | $4,019,000 | +16.0% | 46,885 | +2.9% | 0.95% | +10.1% |
| Q3 2014 | $3,464,000 | -9.7% | 45,585 | -6.4% | 0.86% | -9.6% |
| Q2 2014 | $3,835,000 | +1.8% | 48,710 | -3.0% | 0.96% | -1.0% |
| Q1 2014 | $3,766,000 | -2.3% | 50,210 | +0.6% | 0.97% | +2.9% |
| Q4 2013 | $3,853,000 | – | 49,910 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |